Good morning, you're listening to Markets Desk.
Digital Realty is expanding its footprint in Southeast Asia after Singapore selected the data center operator under its second Call for Application, granting a provisional allocation of fifty megawatts of new capacity at Jurong Island's low-carbon data center park. The move signals continued institutional confidence in AI-driven infrastructure demand across the Asia-Pacific region, and DLR shares will be worth watching on the open.
Shifting to macro risk, Washington is tightening the screws on Tehran. Treasury Secretary Scott Bessent announced a fresh wave of sanctions targeting Iran's remaining trade lifelines, warning that any country or company facilitating Iranian money flows faces serious consequences. Indian equities opened lower on the news, reflecting how quickly geopolitical pressure in the Middle East translates into emerging market sentiment and energy price uncertainty.
On the pharma side, Johnson and Johnson received FDA approval for IMAAVY, its treatment for warm autoimmune hemolytic anemia in adults and pediatric patients twelve and older. The approval adds a meaningful asset to JNJ's immunology pipeline at a time when the company is actively rebuilding its portfolio following its consumer health spinoff, and it reinforces the stock's defensive appeal heading into the back half of the year.
That's the tape. Markets Desk, signing off the floor.
